WST West Pharmaceutical Services, I
Healthcare · Medical Instruments & Supplies
328.20
-7.67%
Sobre l'empresa
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.
Rang 52 setmanes
Anàlisi a fons del dividend
West Pharmaceutical Services, I (WST) operates in the Medical Instruments & Supplies sector. The company currently offers a dividend yield of 0.26%. This yield is within its 5-year historical range of 0.18% to 0.33%, with a 5-year average of 0.24%. Yield Theory suggests the stock is currently valued "fairly." No momentum, value, or overall rating scores are provided in the data.
Historial de dividends
West Pharmaceutical Services, I has maintained a 28-year dividend increase streak, earning it a "Champion" tier classification. The dividend has grown with a 3-year compound annual growth rate (CAGR) of 5.27% and a 5-year CAGR of 5.59%. At this rate, the dividend would double in approximately 12.9 years. Annual dividends per share have been: 0.40 USD (2014), 0.44 USD (2015), 0.48 USD (2016), 0.52 USD (2017), 0.56 USD (2018), 0.60 USD (2019), 0.64 USD (2020), 0.68 USD (2021), 0.72 USD (2022), 0.76 USD (2023), 0.80 USD (2024), and 0.84 USD (2025).
Quantic · Gratis
Desbloqueja l'anàlisi completa
Lectura de la seguretat del dividend, els riscos clau i què cal vigilar.
Generat per IA a partir de les dades de dividends de Quantic · Actualitzat el 24 Jul 2026 · Només informatiu — no és assessorament financer.
Es mostra en anglès — la traducció està en camí.
Historial de preus
Perfil de dividends
Banda de rendibilitat La rendibilitat per dividend actual d'una acció davant del seu propi rang dels últims cinc anys — el mínim, la mitjana i el màxim. A prop del màxim, les accions semblen relativament barates per als ingressos que paguen; a prop del mínim, relativament cares. És la imatge que hi ha darrere de la Teoria del Rendiment per Dividend. Més informació → (5 anys)
Calendari de pagaments
Historial de dividends
Dividend per acció per any
Deute i palanquejament
Últimes xifres del balanç publicades.
seguit per 1
Apareix en aquestes llistes
WST compleix els criteris d'aquests rànquings de dividends.
Nou en la inversió en dividends?
Només informatiu — no és assessorament financer.
Quantic · Gratis
Segueix WST i tota la teva cartera
Rendiment real, seguretat del dividend, ingressos nets d'impostos i el teu camí cap a la llibertat — gratis, sense connexió amb el bróker.